Clinical Trials Logo

Sinusitis clinical trials

View clinical trials related to Sinusitis.

Filter by:

NCT ID: NCT05369039 Not yet recruiting - Chronic Sinusitis Clinical Trials

Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis.

Start date: June 2022
Phase: Phase 2
Study type: Interventional

The current study will be a pilot study for a randomized controlled trial conducted on 60 patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine after approval of the institutional review board and taking informed written consent from every patient before participation in the study. The patients of this study will be randomly and equally distributed among case and control groups to compare the effect of Roflumilust administration with the effect of systemic and local corticosteroids on patients with chronic rhinosinusitis with nasal polyposis

NCT ID: NCT05355207 Not yet recruiting - Clinical trials for Chronic Rhinosinusitis With Nasal Polyps

Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis

Start date: January 2024
Phase: Phase 1
Study type: Interventional

TRL1068 is expected to eliminate the pathogen-protecting biofilm in Chronic Rhinosinusitis, thus making these bacteria substantially more susceptible to established antibiotic treatment regimens. This initial study is to assess overall safety and pharmacokinetics (PK) of TRL1068. The goal of the development program is to demonstrate effectiveness of TRL1068 in difficult to treat bacterial infections such as in CRS.

NCT ID: NCT05301777 Not yet recruiting - Sinusitis Clinical Trials

Computed Tomography Anatomy of the Paranasal Sinuses and Anatomical Variants of Clinical Relevants in Egyptian Adults .

Start date: April 1, 2022
Phase:
Study type: Observational

The aim of this study is to show the anatomy of the paranasal sinuses as delineated by the computed tomography among egyptian adults and to describe the variants which not only predispose to chronic sinusitis but may lead to complications in endoscopic sinonasal surgery.

NCT ID: NCT05167552 Not yet recruiting - Allergic Rhinitis Clinical Trials

Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells

Start date: March 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Treatment of patients with allergic rhinitis and chronic polypous rhinosinusitis with olfactory mucosa-derived mesenchymal stem cells

NCT ID: NCT05157412 Not yet recruiting - Nasal Polyps Clinical Trials

Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps

Start date: March 1, 2022
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of Doxycycline as an adjunct to systemic steroids in the treatment of chronic rhinosinusitis with nasal polyps

NCT ID: NCT05156801 Not yet recruiting - Chronic Sinusitis Clinical Trials

Efficacy of ArchSinus, NasoPore & Propel to Prevent Post-Surgical MT Lateralization and Improve Symptomatic Outcomes

Start date: March 2022
Phase: N/A
Study type: Interventional

This is a multi-center, randomized, single-blinded comparative 3-arm clinical study. This clinical study is designed to compare the efficacy of the ArchSinus stent to the Propel stent (Intersect ENT), and to NasoPore (Stryker) in preventing post-FESS middle turbinate lateralization 3 weeks, 6 weeks, 3 months and 12 months post FESS.

NCT ID: NCT04903418 Not yet recruiting - Maxillary Sinusitis Clinical Trials

Assessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position

Start date: October 2021
Phase:
Study type: Observational

There have been no cross-sectional studies conducted on the Egyptian population studying the relationship between maxillary sinus floor and the maxillary posterior root tips position using CBCT, and whether the maxillary sinus mucosal thickening is associated with periapical lesions as well as periodontal disease. Such study will raise the diagnostic and interpretational abilities of dental radiologists and decision making of oral surgeons and endodontists.

NCT ID: NCT04514120 Not yet recruiting - Clinical trials for Chronic Rhinosinusitis (Diagnosis)

Alsaleh-Javer Endoscopic Sinus Score (AJESS) System

AJESS
Start date: September 2020
Phase: N/A
Study type: Interventional

Several endoscopic scores have been developed to assess Chronic Rhinosinusitis severity like the Modified Lund-Kennedy (MLK). This is a simple score only based on endoscopic signs. We proposed a more descriptive Alsaleh-Javer Endoscopic Sinus Score (AJESS) system which assesses all sinuses and nasal passages based on participant's severity of symptoms too. This would be a more reliable and clinically valid CRS endoscopic score. We aim to study thE AJESS system in 100 participants with stable CRS and 30 participants CRS who are experiencing an exacerbation (worsening of CRS).

NCT ID: NCT04374448 Not yet recruiting - Chronic Sinusitis Clinical Trials

Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery

NIRFICG
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The endoscope is a device placed into the nasal cavity to remove chronic sinus disease or tumor or create access into the skullbase for extensive tumor removal. Indocyanine Green (ICG) is a dye that is injected through an intravenous site and is used to light up vasculature and margins of a tumor during surgery. This helps avoid damage to important vasculature and obtain clear margins during surgery. This study aims to further assess the utility of ICG when operating within the nasal cavity or skullbase.

NCT ID: NCT04278950 Not yet recruiting - Clinical trials for Chronic Rhinosinusitis (Diagnosis)

Povidone-Iodine Rinses as an Adjuvant Therapy Post-Operatively

Start date: February 10, 2020
Phase: N/A
Study type: Interventional

Povidone Iodine solution is a nasal antiseptic. Its application has been shown to be clinically safe, tolerable and effective against bacteria and fungi associated with chronic rhinosinusitis. The purpose of this study is determining the effectiveness of PVP-I in comparison to a placebo for post-operative refractory CRS patients in a randomized controlled trial.